Hemodialysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Hemodialysis Market is Segmented by Product Type (Equipment (Dialysis Machines, Hemodialysis Water Treatment Systems, and Other Hemodialysis Equipment) and Consumables (Dialyzers, Catheters, and Other Hemodialysis Consumables)), Modality (Conventional Long-term Hemodialysis, Short Daily Hemodialysis, and Nocturnal Hemodialysis), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America).

Market Snapshot

Hemodialysis Market 1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The hemodialysis market is projected to register a CAGR of 5.6% during the forecast period.

The COVID-19 pandemic has been continuing to transform the growth of various markets, the immediate impact of the outbreak is varied. While a few industries registered a drop in demand, numerous other markets may continue to remain unscathed and show promising growth opportunities. Initially, the COVID-19 outbreak and the lockdown situation across some countries have shown some challenges on the market studied, due to the on-hold services by hospitals and clinics to prevent the spread of the COVID-19 virus. Additionally, people with existing illnesses, such as acute kidney injury (AKI), chronic kidney disease (CKD), hypertension, and diabetes, are expected to experience a higher-than-average fatality rate. For instance, in 2020, the report published by National Kidney Foundation Inc. stated that people hospitalized with COVID-19 are at significant risk of CKD, which may lead to serious illnesses, like end-stage renal disease. Thus, the rising incidence of kidney failure and chronic renal dysfunction due to COVID-19 is expected to promote market growth over the forecast period.

Moreover, the major factors for the growth of the hemodialysis market include the rising number of end-stage renal disease (ESRD) patients and the increasing incidence of diabetes and hypertension.

The rise in the number of ESRD and shortage in the availability of kidneys for transplant is expected to boost the growth of the market. Chronic kidney disease (CKD) is a condition that causes reduced kidney function over some time. It may develop over many years and lead to end-stage kidney (or renal) disease (ESRD). It has become an enormous public health issue that continues to rise. For instance, as per a 2019 report by the Center for Disease Control and Prevention, 15% of adults in the United States, which accounts for approximately 37 million people, are estimated to have CKD. Additionally, as per the same source, CKD is common among people aged 65 years or older (38%) than in people aged 45–64 years (13%) or 18–44 years (7%). Furthermore, it is more common in women (15%) than men (12%).

Furthermore, high blood pressure (hypertension) and diabetes are the principal causes of kidney disease and kidney failure. In patients with diabetes, the small blood vessels in the body are injured and may cause damage to nerves resulting in improper blood purification by kidneys and emptying bladder, further leading to kidney failure. As per the World Health Organization, in 2019, an estimated 1.13 billion people, worldwide, had hypertension, with most patients (two-thirds) living in low- and middle-income countries. Moreover, hypertension is one of the major causes of premature death, worldwide. Additionally, As per the International Diabetes Federation (IDF) Diabetes Atlas Ninth edition 2019, it was found that globally approximately 463 million adults (20-79 years) were living with diabetes, and by 2045, it is expected to reach 700 million. Thus, owing to the rising burden of kidney failures, there may be a huge demand for hemodialysis equipment resulting in high growth of the market.

Scope of the Report

As per the scope of this report, hemodialysis is the process of purifying the blood of a person whose kidneys are not working normally. The market covers various equipment and consumables that are used for hemodialysis. The hemodialysis market is segmented by product type (equipment (dialysis machines, hemodialysis water treatment systems, other hemodialysis equipment) and consumables (dialyzers, catheters, and other hemodialysis consumables)), modality (conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis), and geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product Type
Dialysis Machines
Hemodialysis Water Treatment Systems
Other Hemodialysis Equipment
Other Hemodialysis Consumables
By Modality
Conventional Long-term Hemodialysis
Short Daily Hemodialysis
Nocturnal hemodialysis
By Geography
North America
United States
United Kingdom
Rest of Europe
Asia Pacific
South Korea
Rest of Asia Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Conventional Long-term Hemodialysis is the Segment by Modality is Expected to Hold Largest Market Share over the Forecast Period

The COVID-19 pandemic has affected hemodialysis procedures. However, to cope with the crisis created by COVID 19, In July 2020, NephroPlus launched India’s first “Dialysis on Wheels” Program where a patient can undergo dialysis inside an ambulance itself that comes to their home. Additionally, the relaxation in lockdown guidelines is increasing the therapeutic procedural rate, which further increases the segment growth.

The hemodialysis market is segmented by modality in three major segments: conventional Long-Term Hemodialysis, Short Daily Hemodialysis, and Nocturnal hemodialysis. Conventional Long-term hemodialysis is expected to hold a large market share owing to the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients.

According to the Organ Procurement and Transplantation Network, around 90,986 people as of February 2021 are waiting for kidney transplants in the United States. Thus, owing to the shortage of kidneys for transplant, the market is expected to witness high growth.

Furthermore, major manufacturers have focused on developing specialized dialysis equipment coupled with growing partnerships and collaboration among market players, which is expected to drive the market’s growth. Currently, various home and in-center hemodialysis machines are available in the market.

In October 2020, Fresenius Medical Care North America (FMCNA) entered into an innovative partnership with Livongo Health, Inc, to improve the lives and outcomes of people with late-stage chronic kidney disease (CKD) by increasing optimal dialysis starts, as well as offer earlier evaluation of transplantation and home dialysis options. Moreover, in 2019, CVS Health initiated a Clinical trial for its new HemoCare Hemodialysis System, a dialysis machine developed for home use in partnership with Segway designer Dean Kamen.


North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is the most COVID-affected country across the world. Initially, due to the lockdown, a delay in diagnosis and treatments is being observed in many of the patients, including end-stage renal disease patients, as a result of a reduction in hospital visits. Hence this factor had affected the hemodialysis market growth in the COVID-19 pandemic.

Moreover, COVID-19 has a high mortality rate among older adults and individuals suffering from chronic diseases, such as chronic kidney diseases (CKD). As per the Centers for Disease Control and Prevention (CDC) 2019, in the United States, about 15% of adults suffer from chronic kidney diseases (CKD). Additionally, in the United States, patients with pre-existing chronic kidney disease (CKD) were considered to be largely susceptible to COVID-19. For instance, a research article by Jennifer E Flythe et al., published in the American Journal of Kidney Diseases 2020, stated that high mortality may be observed in patients with underlying kidney disease and severe COVID-19.

Moreover, the United States is expected to be the largest market for hemodialysis due to better healthcare infrastructure and the presence of major market players. As per the Center for disease control and prevention 2018, 15% of US adults or 37 million people are estimated to have chronic kidney disease common in people aged 65 years or older (38%) than in people aged 45–64 years (13%) or 18–44 years.

Furthermore, as per the Chronic Kidney Disease in the United States, 2019 report, the number of people living with CKD in the United States was 37 million, and CKD is more common in women (15%) than men (12%). Moreover, according to the same report, CKD is one of the costliest disease conditions in the United States, which has been posing an economic burden of USD 83 billion, annually. Additionally, according to the Population Reference Bureau, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. An aging population and a growing risk of chronic kidney disease are projected to significantly boost regional growth.

Furthermore, manufacturers are focusing on developing specialized hemodialysis machines with different interventions. This is expected to impact the end-user experience. In addition, there is also an increase in public healthcare expenditure, coupled with the rising awareness programs, which is expected to drive the growth of the hemodialysis market in the North American region.

Hemodialysis Market - Growth Rate by Region - Image

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of few market players. Some of the market players are Asahi Kasei Corporation, B Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cantel Medical Corp., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic PLC, and Nipro Corporation.

Recent Developments

  • In December 2020, Medtronic launched its Carpediem Cardio-Renal Paediatric Dialysis Emergency Machine in the United States upon receiving Food and Drug Administration's (FDA) marketing authorization. The first machine was installed at Cincinnati Children's Hospital Medical Center.
  • In October 2020, United States-based privately held medical device company, Diality, invested around USD 12.5 million in developing a portable hemodialysis system to address the unmet technology needs of the evolving dialysis industry.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Number of End Stage Renal Disease Patients

      2. 4.2.2 Increasing Incidence of Diabetes and Hypertension

    3. 4.3 Market Restraints

      1. 4.3.1 Risks and Complications Associated with Dialysis

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Equipment

        1. Dialysis Machines

        2. Hemodialysis Water Treatment Systems

        3. Other Hemodialysis Equipment

      2. 5.1.2 Consumables

        1. Dialyzers

        2. Catheters

        3. Other Hemodialysis Consumables

    2. 5.2 By Modality

      1. 5.2.1 Conventional Long-term Hemodialysis

      2. 5.2.2 Short Daily Hemodialysis

      3. 5.2.3 Nocturnal hemodialysis

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Asahi Kasei Corporation

      2. 6.1.2 B Braun Melsungen AG

      3. 6.1.3 Baxter International Inc.

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Cantel Medical Corp.

      6. 6.1.6 DaVita Inc.

      7. 6.1.7 Fresenius Medical Care AG & Co. KGaA

      8. 6.1.8 Medtronic PLC

      9. 6.1.9 Nipro Corporation

      10. 6.1.10 Rockwell Medical Inc.

      11. 6.1.11 Toray Medical Co. Ltd

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Hemodialysis Market market is studied from 2018 - 2026.

The Global Hemodialysis Market is growing at a CAGR of 5.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Asahi Kasei Corporation, Baxter International Inc., Cantel Medical Corp., Fresenius Medical Care AG & Co. KGaA, B Braun Melsungen AG are the major companies operating in Global Hemodialysis Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!